Advertisement

Liver Diseases pp 293-304 | Cite as

Liver Disease in Pregnancy

  • Sheila EswaranEmail author
  • Nancy Reau
Chapter

Abstract

Diagnosis and management of liver disease in women who are pregnant can be challenging. The management starts with an assessment to determine if the patient has pre-existing or coincidental liver disease not related to pregnancy verses liver disease related to pregnancy. Consideration of both the expectant mother and fetus are paramount in the approach to treatment.

Keywords

Pregnancy Acute fatty liver of pregnancy HELLP Intrahepatic cholestasis of pregnancy Preeclampsia Eclampsia trimester 

References

Normal Pregnancy

  1. 1.
    Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16(2):153–68.PubMedCrossRefGoogle Scholar
  2. 2.
    Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost. 2003;29(2):125–30.PubMedCrossRefGoogle Scholar
  3. 3.
    Bacq Y, Zarka O, Bréchot JF, Mariotte N, Vol S, Tichet J, Weill J. Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology. 1996;23(5):1030–4.PubMedCrossRefGoogle Scholar
  4. 4.
    Committee Opinion No ACOG. 640: cell-free DNA screening for fetal aneuploidy. Obstet Gynecol. 2015;126:e31–7.CrossRefGoogle Scholar

Pre-existing or Coincidental Liver Disease During Pregnancy

  1. 5.
    CDC (2008) MMWR 39:1–26. http://www.cdc.gov/mmwr
  2. 6.
    Elinav E, Ben-Dov IZ, Shapira Y, et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology. 2006;130:1129–34.PubMedCrossRefGoogle Scholar
  3. 7.
    Patra S, Kumar A, Trivedi SS, et al. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med. 2007;147:28–33.PubMedCrossRefGoogle Scholar
  4. 8.
    Noor A, Panwala A, Forouhar F, Wu GY. Hepatitis caused by herpes viruses: a review. J Dig Dis. 2018;19(8):446–55.PubMedCrossRefGoogle Scholar
  5. 9.
    Kaufman B, Gandhi SA, Louie E, Rizzi R, Illei P. Herpes simplex virus hepatitis: case report and review. Clin Infect Dis. 1997;24(3):334–8.PubMedCrossRefGoogle Scholar
  6. 10.
    Norvell JP, Blei AT, Jovanovic BD, Levitsky J. Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases. Liver Transpl. 2007;13(10):1428–34.PubMedCrossRefGoogle Scholar
  7. 11.
    ACOG Committee on Practice Bulletins. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy. Obstet Gynecol. 2007;109(6):1489–98.CrossRefGoogle Scholar
  8. 12.
    Pan CQ, Duan ZP, Bhamidimarri KR, et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin J Gastroenterol Hepatol. 2012;10:452–9.CrossRefGoogle Scholar
  9. 13.
    Jaffe A, Brown RS Jr. A review of antiviral use for the treatment of chronic hepatitis B virus infection in pregnant women. Gastroenterol Hepatol (N Y). 2017;13(3):154–63.Google Scholar
  10. 14.
    Schramm C, Herkel J, Beuers U, et al. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol. 2006;101:556–60.PubMedCrossRefGoogle Scholar
  11. 15.
    Lamers MM, van Oijen MG, Pronk M, et al. Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials. J Hepatol. 2010;53:191–8.PubMedCrossRefGoogle Scholar
  12. 16.
    Mahadevan U, Kane S. American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006;131(1):283–311. ReviewPubMedCrossRefGoogle Scholar
  13. 17.
    Marrero JA, Ahn J, Rajender-Reddy K, American College of Gastroenterology. ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol. 2014;109(9):1328–47.PubMedCrossRefGoogle Scholar
  14. 18.
    Shaked O, Siegelman ES, Olthoff K, Reddy KR. Biologic and clinical features of benign solid and cystic lesions of the liver. Clin Gastroenterol Hepatol. 2011;9(7):547–562.e1–4.PubMedCrossRefGoogle Scholar
  15. 19.
    Bis KA, Waxman B. Rupture of the liver associated with pregnancy: a review of the literature and report of 2 cases. Obstet Gynecol Surv. 1976;31(11):763.PubMedCrossRefGoogle Scholar
  16. 20.
    Saegusa T, Ito K, Oba N, et al. Enlargement of multiple cavernous hemangioma of the liver in association with pregnancy. Intern Med. 1995;34:207–11.PubMedCrossRefGoogle Scholar
  17. 21.
    Rifai K, Mix H, Potthoff A, et al. No evidence of substantial growth progression of complications of large focal nodular hyperplasia during pregnancy. Scand J Gastroenterol. 2013;48:88–92.PubMedCrossRefGoogle Scholar

Liver Diseases Specific to Pregnancy

  1. 22.
    Einarson TR, Piwko C, Koren G. Quantifying the global rates of nausea and vomiting of pregnancy: a meta-analysis. J Popul Ther Clin Pharmacol. 2013;20(2):e171–83.PubMedGoogle Scholar
  2. 23.
    Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin no. 189: nausea and vomiting of pregnancy. Obstet Gynecol. 2018;131(1):e15–30.CrossRefGoogle Scholar
  3. 24.
    Abell TL, Riely CA. Hyperemesis gravidarum. Gastroenterol Clin N Am. 1992;21(4):835–49. ReviewGoogle Scholar
  4. 25.
    Outlaw WM, Ibdah JA. Impaired fatty acid oxidation as a cause of liver disease associated with hyperemesis gravidarum. Med Hypotheses. 2005;65(6):1150–3.PubMedCrossRefGoogle Scholar
  5. 26.
    Di Gangi S, Gizzo S, Patrelli TS, Saccardi C, D’Antona D, Nardelli GB. Wernicke’s encephalopathy complicating hyperemesis gravidarum: from the background to the present. J Matern Fetal Neonatal Med. 2012;25:1499–504.PubMedCrossRefGoogle Scholar
  6. 27.
    Eroglu A, Kurkcuoglu C, Karaoglanoglu N, Tekinbas C, Cesur M. Spontaneous esophageal rupture following severe vomiting in pregnancy. Dis Esophagus. 2002;15:242–3.PubMedCrossRefGoogle Scholar
  7. 28.
    Liang SG, Ooka F, Santo A, Kaibara M. Pneumomediastinum following esophageal rupture associated with hyperemesis gravidarum. J Obstet Gynaecol Res. 2002;28:172–5.PubMedCrossRefGoogle Scholar
  8. 29.
    Nguyen N, Deitel M, Lacy E. Splenic avulsion in a pregnant patient with vomiting. Can J Surg. 1995;38:464–5.PubMedGoogle Scholar
  9. 30.
    Mitchell-Jones N, Gallos I, Farren J, Tobias A, Bottomley C, Bourne T. Psychological morbidity associated with hyperemesis gravidarum: a systematic review and meta-analysis. BJOG. 2017;124(1):20–30.CrossRefGoogle Scholar
  10. 31.
    Tsang IS, Katz VL, Wells SD. Maternal and fetal outcomes in hyperemesis gravidarum. Int J Gynaecol Obstet. 1996;55(3):231–5.PubMedCrossRefGoogle Scholar
  11. 32.
    Hallak M, Tsalamandris K, Dombrowski MP, Isada NB, Pryde PG, Evans MI. Hyperemesis gravidarum. Effects on fetal outcome. J Reprod Med. 1996;41(11):871–4.PubMedGoogle Scholar
  12. 33.
    Bottomley C, Bourne T. Management strategies for hyperemesis. Best Pract Res Clin Obstet Gynaecol. 2009;23(4):549–64.PubMedCrossRefGoogle Scholar
  13. 34.
    Laifer SA, Stiller RJ, Siddiqui DS, Dunston-Boone G, Whetham JC. Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. J Matern Fetal Med. 2001;10(2):131–5.PubMedCrossRefGoogle Scholar
  14. 35.
    Lee RH, Goodwin TM, Greenspoon J, Incerpi M. The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol. 2006;26(9):527–32.PubMedCrossRefGoogle Scholar
  15. 36.
    Reyes H, Gonzalez MC, Ribalta J, Aburto H, Matus C, Schramm G, Katz R, Medina E. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med. 1978;88(4):487–93.PubMedCrossRefGoogle Scholar
  16. 37.
    Jacquemin E, Cresteil D, Manouvrier S, Boute O, Hadchouel M. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet. 1999;353(9148):210–1.PubMedCrossRefGoogle Scholar
  17. 38.
    Floreani A, Gervasi MT. New insights on intrahepatic cholestasis of pregnancy. Clin Liver Dis. 2016;20(1):177–89.PubMedCrossRefGoogle Scholar
  18. 39.
    Marschall HU, Wikström Shemer E, Ludvigsson JF, Stephansson O. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study. Hepatology. 2013;58(4):1385–91.PubMedCrossRefGoogle Scholar
  19. 40.
    Ropponen A, Sund R, Riikonen S, Ylikorkala O, Aittomäki K. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology. 2006;43(4):723–8.PubMedCrossRefGoogle Scholar
  20. 41.
    Garcia-Flores J, Canamares M, Cruceyra M, et al. Clinical value of maternal bile acid quantification in intrahepatic cholestasis of pregnancy as an adverse perinatal outcome predictor. Gynecol Obstet Invest. 2015;79:222–8.PubMedCrossRefGoogle Scholar
  21. 42.
    Geenes V, Chappell LC, Seed PT, et al. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology. 2014;59:1482–91.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 43.
    Puljic A, Kim E, Page J, Esakoff T, Shaffer B, LaCoursiere DY, Caughey AB. The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age. Am J Obstet Gynecol. 2015;212(5):667.e1–5.CrossRefGoogle Scholar
  23. 44.
    Bacq Y, Sentilhes L, Reyes HB, Glantz A, Kondrackiene J, Binder T, Nicastri PL, Locatelli A, Floreani A, Hernandez I, Di Martino V. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology. 2012;143(6):1492–501.PubMedCrossRefGoogle Scholar
  24. 45.
    Gurung V, Middleton P, Milan SJ, Hague W, Thornton JG. Interventions for treating cholestasis in pregnancy. Cochrane Database Syst Rev. 2013;6:CD000493.Google Scholar
  25. 46.
    American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–31.CrossRefGoogle Scholar
  26. 47.
    Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1–7.PubMedCrossRefGoogle Scholar
  27. 48.
    Walters BN. Preeclamptic angina—a pathognomonic symptom of preeclampsia. Hypertens Pregnancy. 2011;30(2):117–24.PubMedCrossRefGoogle Scholar
  28. 49.
    Kozic JR, Benton SJ, Hutcheon JA, et al. Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia. J Obstet Gynaecol Can. 2011;33:995–1004.PubMedCrossRefGoogle Scholar
  29. 50.
    Thangaratinam S, Koopmans CM, Iyengar S, et al. TIPPS (Tests in Prediction of Preeclampsia’s Severity) Review Group. Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review. Acta Obstet Gynecol Scand. 2011;90:574–85.PubMedCrossRefGoogle Scholar
  30. 51.
    Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130–7.PubMedCrossRefGoogle Scholar
  31. 52.
    Churchill D, Duley L, Thornton JG, et al. Interventionist versus expectant care for severe pre- eclampsia between 24 and 34 weeks’ gestation. Cochrane Database Syst Rev. 2013;7:CD003106.Google Scholar
  32. 53.
    Ibdah JA, Bennett MJ, Rinaldo P, Zhao Y, Gibson B, Sims HF, Strauss AW. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med. 1999;340(22):1723–31.PubMedCrossRefGoogle Scholar
  33. 54.
    Knight M, Nelson-Piercy C, Kurinczuk JJ, Spark P, Brocklehurst P, UK Obstetric Surveillance System. A prospective national study of acute fatty liver of pregnancy in the UK. Gut. 2008;57(7):951–6.PubMedCrossRefGoogle Scholar
  34. 55.
    Fitzpatrick KE, Hinshaw K, Kurinczuk JJ, et al. Risk factors, management, and outcomes of hemolysis, elevated liver enzymes, and low platelets syndrome and elevated liver enzymes, low platelets syndrome. Obstet Gynecol. 2014;123:618–27.PubMedCrossRefGoogle Scholar
  35. 56.
    Erkılınç S, Eyi EGY. Factors contributing to adverse maternal outcomes in patients with HELLP syndrome. J Matern Fetal Neonatal Med. 2018;31(21):2870–6.PubMedCrossRefGoogle Scholar
  36. 57.
    Theilen LH, Fraser A, Hollingshaus MS, Schliep KC, Varner MW, Smith KR, Esplin MS. All-cause and cause-specific mortality after hypertensive disease of pregnancy. Obstet Gynecol. 2016;128(2):238–44.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 58.
    Guo Q, Yang Z, Guo J, Zhang L, Gao L, Zhou B, Shi Q. Hepatic infarction induced by HELLP syndrome: a case report and review of the literature. BMC Pregnancy Childbirth. 2018;18(1):191.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 59.
    Gutovich JM, Van Allan RJ. Hepatic artery embolization for hepatic rupture in HELLP syndrome. J Vasc Interv Radiol. 2016;27(12):1931–3.PubMedCrossRefGoogle Scholar
  39. 60.
    Zarrinpar A, Farmer DG, Ghobrial RM, et al. Liver transplantation for HELLP syndrome. Am Surg. 2007;73:1013.PubMedGoogle Scholar
  40. 61.
    Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993;169(4):1000.PubMedCrossRefGoogle Scholar
  41. 62.
    Barnhart L. HELLP syndrome and the effects on the neonate. Neonatal Netw. 2015;34(5):269–73.PubMedCrossRefGoogle Scholar
  42. 63.
    Cavaignac-Vitalis M, Vidal F, Simon-Toulza C, Boulot P, Guerby P, Chantalat E, Parant O. Conservative versus active management in HELLP syndrome: results from a cohort study. J Matern Fetal Neonatal Med. 2017;21:1–7.Google Scholar
  43. 64.
    Martin JN Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol. 2006;195(4):914–34.PubMedCrossRefGoogle Scholar
  44. 65.
    Martin JN Jr, Owens MY, Keiser SD, et al. Standardized Mississippi Protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity. Hypertens Pregnancy. 2012;31:79–90.PubMedCrossRefGoogle Scholar
  45. 66.
    Woudstra DM, Chandra S, Hofmeyr GJ, et al. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev. 2010;2010:CD008148.Google Scholar
  46. 67.
    Fonseca JE, Méndez F, Cataño C, Arias F. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol. 2005;193(5):1591–8.PubMedCrossRefGoogle Scholar

Special liver Related Considerations in Pregnancy

  1. 68.
    Committee on Obstetric Practice. Committee opinion no. 723: guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol. 2017;130(4):e210–6.CrossRefGoogle Scholar
  2. 69.
    Torloni MR, Vedmedovska N, Merialdi M, Betrán AP, Allen T, González R, Platt LD, ISUOG-WHO Fetal Growth Study Group. Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta-analysis. Ultrasound Obstet Gynecol. 2009;33(5):599–608.PubMedCrossRefGoogle Scholar
  3. 70.
    Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP, Piscaglia F, Wilson SR, Barr RG, Chammas MC, Chaubal NG, Chen MH, Clevert DA, Correas JM, Ding H, Forsberg F, Fowlkes JB, Gibson RN, Goldberg BB, Lassau N, Leen EL, Mattrey RF, Moriyasu F, Solbiati L, Weskott HP, Xu HX, World Federation for Ultrasound in Medicine; European Federation of Societies for Ultrasound. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS ultrasound. Med Biol. 2013;39(2):187–210.Google Scholar
  4. 71.
    De Santis M, Straface G, Cavaliere AF, Carducci B, Caruso A. Gadolinium periconceptional exposure: pregnancy and neonatal outcome. Acta Obstet Gynecol Scand. 2007;86:99–101.PubMedCrossRefGoogle Scholar
  5. 72.
    Ray JG, Vermeulen MJ, Bharatha A, Montanera WJ, Park AL. Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA. 2016;316(9):952–61.PubMedCrossRefGoogle Scholar
  6. 73.
    Holt R, Abramowicz JS. Quality and safety of obstetric practices using new modalities- ultrasound, MR, and CT. Clin Obstet Gynecol. 2017;60(3):546–61.PubMedCrossRefGoogle Scholar
  7. 74.
    Kochupillai N, Pandav CS, Godbole MM, Mehta M, Ahuja MM. Iodine deficiency and neonatal hypothyroidism. Bull World Health Organ. 1986;64(4):547–51.PubMedPubMedCentralGoogle Scholar
  8. 75.
    Ludvigsson JF, Marschall HU, Hagström H, Höijer J, Stephansson O. Pregnancy outcome in women undergoing liver biopsy during pregnancy: a nationwide population-based cohort study. Hepatology. 2018;68(2):625–33.PubMedCrossRefGoogle Scholar
  9. 76.
    Mammen T, Keshava SN, Eapen CE, Raghuram L, Moses V, Gopi K, Babu NS, Ramachandran J, Kurien G. Transjugular liver biopsy: a retrospective analysis of 601 cases. J Vasc Interv Radiol. 2008;19(3):351–8.PubMedCrossRefGoogle Scholar
  10. 77.
    Hari A, Nair HK, De Gottardi A, Baumgartner I, Dufour JF, Berzigotti A. Diagnostic hepatic haemodynamic techniques: safety and radiation exposure. Liver Int. 2017;37(1):148–54.PubMedCrossRefGoogle Scholar
  11. 78.
    Cappell MS. Risks versus benefits of gastrointestinal endoscopy during pregnancy. Nat Rev Gastroenterol Hepatol. 2011;8(11):610–34.PubMedCrossRefGoogle Scholar
  12. 79.
    ASGE Standard of Practice Committee, Shergill AK, Ben-Menachem T, Chandrasekhara V, Chathadi K, Decker GA, Evans JA, Early DS, Fanelli RD, Fisher DA, Foley KQ, Fukami N, Hwang JH, Jain R, Jue TL, Khan KM, Lightdale J, Pasha SF, Sharaf RN, Dominitz JA, Cash BD. Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc. 2012;76(1):18–24.PubMedCrossRefGoogle Scholar
  13. 80.
    Qadeer MA, Vargo JJ, Khandwala F, Lopez R, Zuccaro G. Propofol versus traditional sedative agents for gastrointestinal endoscopy: a meta-analysis. Clin Gastroenterol Hepatol. 2005;3(11):1049–56.PubMedCrossRefGoogle Scholar
  14. 81.
    Savas N. Gastrointestinal endoscopy in pregnancy. World J Gastroenterol. 2014;20(41):15241–52.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 82.
    Tan J, Surti B, Saab S. Pregnancy and cirrhosis. Liver Transpl. 2008;14(8):1081–91.PubMedCrossRefGoogle Scholar
  16. 83.
    Starkel P, Horsmans Y, Geubel A. Endoscopic band ligation: a safe technique to control bleeding esophageal varices in pregnancy. Gastrointest Endosc. 1998;48:212–4.PubMedCrossRefGoogle Scholar
  17. 84.
    Iwase H, Morise K, Kawase T, Horiuchi Y. Endoscopic injection sclerotherapy for esophageal varices during pregnancy. J Clin Gastroenterol. 1994;18:80–3.PubMedCrossRefGoogle Scholar
  18. 85.
    Ghidirim G, Mishin I, Dolghii A, Lupashcu A. Prophylactic endoscopic band ligation of esophageal varices during pregnancy. J Gastrointestin Liver Dis. 2008;17:236–7.PubMedGoogle Scholar
  19. 86.
    Lodato F, Cappelli A, Montagnani M, Colecchia A, Festi D, Azzaroli F, Compagnone G, Cecinato P, Golfieri R, Mazzella G. Transjugular intrahepatic portosystemic shunt: a case report of rescue management of unrestrainable variceal bleeding in a pregnant woman. Dig Liver Dis. 2008;40:387–90.PubMedCrossRefGoogle Scholar
  20. 87.
    Wildberger JE, Vorwerk D, Winograd R, Stargardt A, Busch N, Gunther RW. New TIPS placement in pregnancy in recurrent esophageal varices hemorrhage—assessment of fetal radiation exposure. Rofo. 1998;169:429–43.PubMedCrossRefGoogle Scholar
  21. 88.
    Sharma SS, Maharshi S. Two stage endoscopic approach for management of choledocholithiasis during pregnancy. J Gastrointestin Liver Dis. 2008;17:183–5.PubMedGoogle Scholar
  22. 89.
    Shelton J, Linder JD, Rivera-Alsina ME, Tarnasky PR. Commitment, confirmation, and clearance: new techniques for nonradiation ERCP during pregnancy (with videos). Gastrointest Endosc. 2008;67:364–8.PubMedCrossRefGoogle Scholar
  23. 90.
    Roumieu F, Ponchon T, Audra P, Gaucherand P. Acute pancreatitis in pregnancy: place of the different explorations (magnetic resonance cholangiopancreatography, endoscopic ultrasonography) and their therapeutic consequences. Eur J Obstet Gynecol Reprod Biol. 2008;140:141–2.PubMedCrossRefGoogle Scholar

Cirrhosis and Portal Hypertension

  1. 91.
    Shaheen AA, Myers RP. The outcomes of pregnancy in patients with cirrhosis: a population-based study. Liver Int. 2010;30(2):275–8.PubMedCrossRefGoogle Scholar
  2. 92.
    Russell MA, Craigo SD. Cirrhosis and portal hypertension in pregnancy. Semin Perinatol. 1998;22:156–65.PubMedCrossRefGoogle Scholar
  3. 93.
    Rasheed SM, Abdel Monem AM, Abd Ellah AH, et al. Prognosis and determinants of pregnancy outcome among patients with post-hepatitis liver cirrhosis. Int J Gynaecol Obstet. 2013;121:247–51.PubMedCrossRefGoogle Scholar
  4. 94.
    Palatnik A, Rinella ME. Medical and obstetric complications among pregnant women with liver cirrhosis. Obstet Gynecol. 2017;129(6):1118–23.PubMedCrossRefGoogle Scholar
  5. 95.
    Britton RC. Pregnancy and esophageal varices. Am J Surg. 1982;143:421–5.PubMedCrossRefGoogle Scholar
  6. 96.
    Pajor A, Lehoczky D. Pregnancy and extrahepatic portal hypertension. Gynecol Obstet Investig. 1990;30:193–7.CrossRefGoogle Scholar
  7. 97.
    Hillemanns P, Knitza R, Müller-Höcker J. Rupture of splenic artery aneurysm in a pregnant patient with portal hypertension. Am J Obstet Gynecol. 1996;174(5):1665.PubMedCrossRefGoogle Scholar
  8. 98.
    Benjaminov FS, Heathcote J. Liver disease in pregnancy. Am J Gastroenterol. 2004;99:2479–88.PubMedCrossRefGoogle Scholar
  9. 99.
    Pasha SF, Gloviczki P, Stanson AW, Kamath PS. Splanchnic artery aneurysms. Mayo Clin Proc. 2007;82:472–9.PubMedCrossRefGoogle Scholar
  10. 100.
    Heriot JA, Steven CM, Sattin RS. Elective forceps delivery and extradural anaesthesia in a primigravida with portal hypertension and oesophageal varices. Br J Anaesth. 1996;76:325–7.PubMedCrossRefGoogle Scholar
  11. 101.
    Cundy TF, O’Grady JG, Williams R. Recovery of menstruation and pregnancy after liver transplantation. Gut. 1990;31:337–8.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 102.
    Douglas NC, Shah M, Sauer MV. Fertility and reproductive disorders in female solid organ transplant recipients. Semin Perinatol. 2007;31(6):332–8.. Review. Erratum in: Semin Perinatol 2008;32(1):67PubMedCrossRefGoogle Scholar
  13. 103.
    Mass K, Quint EH, Punch MR, et al. Gynecological and reproductive function after liver transplantation. Transplantation. 1996;62:476–9.PubMedCrossRefGoogle Scholar
  14. 104.
    de Koning ND, Haagsma EB. Normalization of menstrual pattern after liver transplantation: consequences for contraception. Digestion. 1990;46:239–41.PubMedCrossRefGoogle Scholar
  15. 105.
    Sarkar M, Bramham K, Moritz MJ, Coscia L. Reproductive health in women following abdominal organ transplant. Am J Transplant. 2018;18(5):1068–76.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 106.
    Christopher V, Al-Chalabi T, Richardson PD, et al. Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Liver Transpl. 2006;12:1138–43.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Rush University Medical CenterChicagoUSA

Personalised recommendations